4 Questions pharma leaders can’t skip before letting AI act
Nataliya Andreychuk explains what teams must do before letting AI act on their behalf, and how that groundwork becomes a competitive advantage.
Newsletters and Deep Dive digital magazine
Nataliya Andreychuk explains what teams must do before letting AI act on their behalf, and how that groundwork becomes a competitive advantage.
In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.
Anthropic says it is working with nine of the top 10 pharma groups in its IPO prospectus, which also reiterates AI's "existential risks to humanity."
The UK government will unveil a big investment package in AI in the Budget this week, headlined by £100m in funding for an AI Biosecurity Lab.
NICE has backed temporary NHS use of five AI tools that can help detect prostate cancer on MRI scans, while more evidence on their value is gathered.
Editor's Picks
Newsletters and Deep Dive
digital magazine